The cell frequency of CD19+/CD38hi/CD24hi/CXCR7+/IL-10+ was higher in pSS patients without clinical activity when compared with pSS patients with clinically active disease and healthy controls (P < 0.05) (Table 2; Figure 4J). This evidence concerns the gene CD19 and peeling skin syndrome.